EMFAT
Emerald Mutual Fund Advisers Trust Portfolio holdings
AUM
$1.64B
This Quarter Return
+38.31%
1 Year Return
+51.67%
3 Year Return
+272.14%
5 Year Return
+503.14%
10 Year Return
+2,013.48%
AUM
$2.87B
AUM Growth
+$2.87B
(+27%)
Cap. Flow
+$80.9M
Cap. Flow
% of AUM
2.81%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
366
New
53
Increased
96
Reduced
56
Closed
140
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$30.2M |
| 2 |
Eastern Bankshares
EBC
|
$28.6M |
| 3 |
Ocular Therapeutix
OCUL
|
$23.2M |
| 4 |
Arvinas
ARVN
|
$20.6M |
| 5 |
MediaAlpha
MAX
|
$20M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$39.8M |
| 2 |
TopBuild
BLD
|
$37.1M |
| 3 |
Twist Bioscience
TWST
|
$35.7M |
| 4 |
Freshpet
FRPT
|
$23.7M |
| 5 |
QTS
QTS REALTY TRUST, INC.
QTS
|
$23.3M |
Sector Composition
| 1 | Healthcare | 22.68% |
| 2 | Technology | 19.38% |
| 3 | Consumer Discretionary | 14.56% |
| 4 | Industrials | 13.26% |
| 5 | Financials | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New Fortress Energy
NFE
$622M
| $30.3M | 1.05% |
565,078
-87,670
| -13% | -$4.7M |
|
|
27
Ultragenyx Pharmaceutical
RARE
$3.03B
| $30.2M | 1.05% |
+218,390
| New | +$30.2M |
|
28
Avient
AVNT
$3.34B
| $30M | 1.04% |
744,567
+216,029
| +41% | +$8.7M |
|
29
AtriCure
ATRC
$1.73B
| $28.8M | 1% |
518,036
+40,972
| +9% | +$2.28M |
|
|
30
Eastern Bankshares
EBC
$3.37B
| $28.6M | 1% |
+1,755,226
| New | +$28.6M |
|
31
Five Below
FIVE
$8.32B
| $28.3M | 0.98% |
161,537
-16,265
| -9% | -$2.85M |
|
32
United Therapeutics
UTHR
$18B
| $28.2M | 0.98% |
185,969
+11,923
| +7% | +$1.81M |
|
33
Q2 Holdings
QTWO
$4.82B
| $27.4M | 0.95% |
216,770
+7,102
| +3% | +$899K |
|
34
LiveRamp
RAMP
$1.79B
| $27.2M | 0.95% |
371,906
+73,324
| +25% | +$5.37M |
|
35
Coherent
COHR
$13.7B
| $27.2M | 0.95% |
357,808
-44,544
| -11% | -$3.38M |
|
36
Planet Fitness
PLNT
$8.52B
| $26.8M | 0.93% |
344,843
-78,305
| -19% | -$6.08M |
|
37
Yeti Holdings
YETI
$2.83B
| $26.3M | 0.92% |
384,117
+15,579
| +4% | +$1.07M |
|
38
Karyopharm Therapeutics
KPTI
$60.9M
| $25.7M | 0.89% |
1,661,236
+211,719
| +15% | +$3.28M |
|
|
MODN
39
DELISTED
MODEL N, INC.
MODN
| $25.7M | 0.89% |
719,776
-18,586
| -3% | -$663K |
|
40
Lattice Semiconductor
LSCC
$9.1B
| $25.3M | 0.88% |
552,690
+18,629
| +3% | +$854K |
|
|
CCXI
41
DELISTED
ChemoCentryx, Inc.
CCXI
| $25.3M | 0.88% |
408,828
+44,171
| +12% | +$2.74M |
|
42
Immunovant
IMVT
$2.88B
| $25.3M | 0.88% |
547,314
+44,441
| +9% | +$2.05M |
|
43
Addus HomeCare
ADUS
$2.07B
| $25.2M | 0.88% |
215,036
+6,894
| +3% | +$807K |
|
|
AZEK
44
DELISTED
The AZEK Co
AZEK
| $24.7M | 0.86% |
641,819
+29,210
| +5% | +$1.12M |
|
|
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $23.7M | 0.83% |
308,828
+198,677
| +180% | +$15.3M |
|
|
46
Ocular Therapeutix
OCUL
$2.24B
| $23.2M | 0.81% |
+1,121,628
| New | +$23.2M |
|
47
Onto Innovation
ONTO
$5B
| $22.9M | 0.8% |
482,209
+152,729
| +46% | +$7.26M |
|
48
Semtech
SMTC
$5B
| $22.8M | 0.79% |
316,872
+52,368
| +20% | +$3.78M |
|
49
Taylor Morrison
TMHC
$6.68B
| $22.5M | 0.78% |
875,381
-130,467
| -13% | -$3.35M |
|
50
Installed Building Products
IBP
$7.15B
| $22.4M | 0.78% |
219,768
+8,252
| +4% | +$841K |
|